ClinicalTrials.Veeva
Menu

Find clinical trials for Lymphoma in St Louis, MO

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

B-Cell Lymphoma
Non-Hodgkin Lymphoma
Diffuse Large B-Cell Lymphoma
Leukemia
Precursor Cell Lymphoblastic Leukemia-Lymphoma
B-Cell Chronic Lymphocytic Leukemia
Lymphoid Leukemia

Lymphoma trials near St Louis, MO, USA:

A Safety and Preliminary Efficacy Study of CC-99282, Alone and in Combination With Anti-lymphoma Agents in Participants With Relapsed or Refractory Non-Hodgkin Lymphomas (R/R NHL)

The purpose of this study is to evaluate the safety, tolerability, and preliminary efficacy of CC-99282 alone and in combination with anti-lymphoma...

Active, not recruiting
Lymphoma, Non-Hodgkin
Drug: Obinutuzumab
Drug: CC-99282

Phase 1, Phase 2

Celgene
Celgene

Saint Louis, Missouri, United States and 68 other locations

order to see how well it works in patients with untreated follicular lymphoma. Mosunetuzumab is an antibody that has been engineered to atta...

Active, not recruiting
Lymphoma, Follicular
Follicular Lymphoma
Drug: Polatuzumab vedotin
Drug: Mosunetuzumab

Phase 2

The Washington University
The Washington University

Saint Louis, Missouri, United States

of TLN-121 as a single agent and in combination with other anti-lymphoma therapies in patients with relapsed or refractory Non-Hodgkin Lymphomas...

Enrolling
Lymphoma
Lymphoma, Non Hodgkin
Drug: TLN-254
Drug: TLN-121

Phase 1

Treeline Biosciences, Inc.

St Louis, Missouri, United States and 8 other locations

autologous stem cell transplant for patients with aggressive B cell lymphomas. Mosunetuzumab is an antibody that has been engineered to atta...

Enrolling
Follicular Lymphoma Grade 3
B Cell Lymphoma
Drug: Mosunetuzumab

Phase 1

The Washington University
The Washington University

Saint Louis, Missouri, United States

B-cell Lymphoma is an aggressive and rare cancer of a type of immune cells (a white blood cell responsible for fighting infections). Classic...

Active, not recruiting
Classic Follicular Lymphoma
Diffuse Large B-Cell Lymphoma
Drug: Epcoritamab

Phase 2

Genmab
Genmab

Chesterfield, Missouri, United States and 71 other locations

primary purpose of this study is to evaluate the anti-tumor activity of TLN-254 monotherapy in participants with relapsed or refractory T-cell lymphoma...

Enrolling
Lymphoma
Drug: TLN-254

Phase 1

Treeline Biosciences, Inc.

St Louis, Missouri, United States and 4 other locations

This study will characterize the safety and clinical benefit of valemetostat tosylate in participants with relapsed/refractory peripheral T-cell lymphoma...

Active, not recruiting
Relapsed/Refractory Peripheral T-Cell Lymphoma
Adult T Cell Leukemia/Lymphoma
Drug: Valemetostat Tosylate

Phase 2

Daiichi Sankyo
Daiichi Sankyo

Saint Louis, Missouri, United States and 59 other locations

and preliminary efficacy of relatlimab plus nivolumab in pediatric and young adult participants with recurrent or refractory classical Hodgkin lymphoma...

Enrolling
Lymphoma, Non-Hodgkin
Hodgkin Disease
Drug: Relatlimab
Drug: Nivolumab

Phase 1, Phase 2

Bristol-Myers Squibb (BMS)
Bristol-Myers Squibb (BMS)

St Louis, Missouri, United States and 75 other locations

treatment of advanced classical Hodgkin lymphoma(HL)...

Active, not recruiting
Hodgkin Lymphoma
Drug: vinblastine
Drug: brentuximab vedotin

Phase 3

Takeda
Takeda

Saint Louis, Missouri, United States and 215 other locations

chemotherapy in patients with relapsed/refractory aggressive B cell lymphoma. The hypothesis of this study is that mosunetuzumab can be safe...

Active, not recruiting
Transformed B-Cell Lymphoma
Large B-cell Lymphoma
Drug: ICE
Drug: DHAX

Phase 1

The Washington University
The Washington University

St Louis, Missouri, United States

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems